659 related articles for article (PubMed ID: 18030330)
21. [Analysis of diffuse large B-cell lymphoma heterogeneity based on coupled two-way clustering].
Li L; Li X; Chen YH; Guo Z; Jiang W; Zhagn RJ; Rao SQ
Yi Chuan; 2006 Sep; 28(9):1129-34. PubMed ID: 16963424
[TBL] [Abstract][Full Text] [Related]
22. Risk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer patients using an RT-PCR based prognostic expression signature.
Tutt A; Wang A; Rowland C; Gillett C; Lau K; Chew K; Dai H; Kwok S; Ryder K; Shu H; Springall R; Cane P; McCallie B; Kam-Morgan L; Anderson S; Buerger H; Gray J; Bennington J; Esserman L; Hastie T; Broder S; Sninsky J; Brandt B; Waldman F
BMC Cancer; 2008 Nov; 8():339. PubMed ID: 19025599
[TBL] [Abstract][Full Text] [Related]
23. Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers.
Oh DS; Troester MA; Usary J; Hu Z; He X; Fan C; Wu J; Carey LA; Perou CM
J Clin Oncol; 2006 Apr; 24(11):1656-64. PubMed ID: 16505416
[TBL] [Abstract][Full Text] [Related]
24. 'Gene shaving' as a method for identifying distinct sets of genes with similar expression patterns.
Hastie T; Tibshirani R; Eisen MB; Alizadeh A; Levy R; Staudt L; Chan WC; Botstein D; Brown P
Genome Biol; 2000; 1(2):RESEARCH0003. PubMed ID: 11178228
[TBL] [Abstract][Full Text] [Related]
25. DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status.
Flanagan JM; Cocciardi S; Waddell N; Johnstone CN; Marsh A; Henderson S; Simpson P; da Silva L; ; Khanna K; Lakhani S; Boshoff C; Chenevix-Trench G
Am J Hum Genet; 2010 Mar; 86(3):420-33. PubMed ID: 20206335
[TBL] [Abstract][Full Text] [Related]
26. Improved personalized survival prediction of patients with diffuse large B-cell Lymphoma using gene expression profiling.
Mosquera Orgueira A; Díaz Arias JÁ; Cid López M; Peleteiro Raíndo A; Antelo Rodríguez B; Aliste Santos C; Alonso Vence N; Bendaña López Á; Abuín Blanco A; Bao Pérez L; González Pérez MS; Pérez Encinas MM; Fraga Rodríguez MF; Bello López JL
BMC Cancer; 2020 Oct; 20(1):1017. PubMed ID: 33087075
[TBL] [Abstract][Full Text] [Related]
27. Robust identification of molecular phenotypes using semi-supervised learning.
Roder H; Oliveira C; Net L; Linstid B; Tsypin M; Roder J
BMC Bioinformatics; 2019 May; 20(1):273. PubMed ID: 31138112
[TBL] [Abstract][Full Text] [Related]
28. Robust stratification of breast cancer subtypes using differential patterns of transcript isoform expression.
Stricker TP; Brown CD; Bandlamudi C; McNerney M; Kittler R; Montoya V; Peterson A; Grossman R; White KP
PLoS Genet; 2017 Mar; 13(3):e1006589. PubMed ID: 28263985
[TBL] [Abstract][Full Text] [Related]
29. Network-based approach to identify prognostic biomarkers for estrogen receptor-positive breast cancer treatment with tamoxifen.
Liu R; Guo CX; Zhou HH
Cancer Biol Ther; 2015; 16(2):317-24. PubMed ID: 25756514
[TBL] [Abstract][Full Text] [Related]
30. Estrogen independent gene expression defines clinically relevant subgroups of estrogen receptor positive breast cancer.
Hallett RM; Hassell JA
BMC Cancer; 2014 Nov; 14():871. PubMed ID: 25420785
[TBL] [Abstract][Full Text] [Related]
31. Exploring the spatial dimension of estrogen and progesterone signaling: detection of nuclear labeling in lobular epithelial cells in normal mammary glands adjacent to breast cancer.
Grote A; Abbas M; Linder N; Kreipe HH; Lundin J; Feuerhake F
Diagn Pathol; 2014; 9 Suppl 1(Suppl 1):S11. PubMed ID: 25565114
[TBL] [Abstract][Full Text] [Related]
32. Breast cancer in Ethiopia: evidence for geographic difference in the distribution of molecular subtypes in Africa.
Hadgu E; Seifu D; Tigneh W; Bokretsion Y; Bekele A; Abebe M; Sollie T; Merajver SD; Karlsson C; Karlsson MG
BMC Womens Health; 2018 Feb; 18(1):40. PubMed ID: 29444670
[TBL] [Abstract][Full Text] [Related]
33. Apoptosis-, proliferation, immune function-, and drug resistance- related genes in ER positive, HER2 positive and triple negative breast cancer.
Kolacinska A; Chalubinska J; Zawlik I; Szymanska B; Borowska-Garganisz E; Nowik M; Fendler W; Kubiak R; Pawlowska Z; Morawiec Z; Szemraj J
Neoplasma; 2012; 59(4):424-32. PubMed ID: 22489698
[TBL] [Abstract][Full Text] [Related]
34. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].
Zhang HM; Zhang BN; Xuan LX; Zhao P
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):447-51. PubMed ID: 19950556
[TBL] [Abstract][Full Text] [Related]
35. Molecular signatures of estrogen receptor-associated genes in breast cancer predict clinical outcome.
Wittliff JL; Kruer TL; Andres SA; Smolenkova I
Adv Exp Med Biol; 2008; 617():349-57. PubMed ID: 18497058
[TBL] [Abstract][Full Text] [Related]
36. [Clinical features and prognosis analysis of different breast cancer molecular subtypes].
Yang Q; Chen J; Li HJ; Yu M; Tian CX; Lü Q
Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):42-6. PubMed ID: 21575463
[TBL] [Abstract][Full Text] [Related]
37. Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors.
Pusztai L; Ayers M; Stec J; Clark E; Hess K; Stivers D; Damokosh A; Sneige N; Buchholz TA; Esteva FJ; Arun B; Cristofanilli M; Booser D; Rosales M; Valero V; Adams C; Hortobagyi GN; Symmans WF
Clin Cancer Res; 2003 Jul; 9(7):2406-15. PubMed ID: 12855612
[TBL] [Abstract][Full Text] [Related]
38. Toward the precision breast cancer survival prediction utilizing combined whole genome-wide expression and somatic mutation analysis.
Zhang Y; Yang W; Li D; Yang JY; Guan R; Yang MQ
BMC Med Genomics; 2018 Nov; 11(Suppl 5):104. PubMed ID: 30454048
[TBL] [Abstract][Full Text] [Related]
39. ER-/PR+/HER2- breast cancer type shows the highest proliferative activity among all other combined phenotypes and is more common in young patients: Experience with 6643 breast cancer cases.
Arena V; Pennacchia I; Vecchio FM; Carbone A
Breast J; 2019 May; 25(3):381-385. PubMed ID: 30916428
[TBL] [Abstract][Full Text] [Related]
40. 18F-FDG PET of locally invasive breast cancer and association of estrogen receptor status with standardized uptake value: microarray and immunohistochemical analysis.
Osborne JR; Port E; Gonen M; Doane A; Yeung H; Gerald W; Cook JB; Larson S
J Nucl Med; 2010 Apr; 51(4):543-50. PubMed ID: 20237034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
